1887

Abstract

Summary

The susceptibilities of 40 strains of various species to 10 classes of antimicrobial agents were compared by a broth microdilution method. the strains tested comprised 20 strains of four AIDS-associated species – (1 strain), (5 strains), (6 strains) and (8 strains) – nine strains of the urogenital tract species and 11 strains of . the results demonstrated wide variation in the susceptibilities of the different spp. to different classes of antimicrobial agent. All the mycoplasmas were susceptible or highly susceptible to the fluoroquinolones, with sparfloxacin the most active, and to the diterpine antibiotic tiamulin. and strains were also highly susceptible to the macrolides, particularly azithromycin and had similar antibiotic susceptibility patterns to most other antimicrobial agents. However, all strains of were resistant to streptomycin (MIC 250–>500 mg/L) whereas all isolates, except the MAC strain, were susceptible (MICs 1.25–12.5 mg/L). isolates varied considerably in their susceptibility to macrolides (MIC range azithromycin 0.0025–>100 mg/L). strains were susceptible to the tetracyclines, lincosamides and mupirocin, but varied in susceptibility to aminoglycosides. Most strains were susceptible to the tetracyclines and all were susceptible to clindamycin and mupirocin. GTU 54 was susceptible to azithromycin, the tetracyclines and lincosamides as well as to the fluoroquinolones and tiamulin.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-47-12-1115
1998-12-01
2022-06-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/47/12/medmicro-47-12-1115.html?itemId=/content/journal/jmm/10.1099/00222615-47-12-1115&mimeType=html&fmt=ahah

References

  1. Lo S. C., Shih J. W-K., Yang N.-Y., Ou C.-Y., Wang R. Y-H. A novel virus-like infectious agent in patients with AIDS. Am J Trop Med Hyg 1989; 40:213–226
    [Google Scholar]
  2. Montagnier L., Berneman D., Guétard D. Inhibition de l’infectionsite de souches prototypes du VIH par des anticorps dirigés contre une sequence peptidique de mycoplasme. CR Acad Sci 1990 Paris t 311, Série 111:425–430
    [Google Scholar]
  3. Dawson M. S., Hayes M. M., Wang R. Y-H., Armstrong D., Kundsin R. B., Lo S. C. Detection and isolation of Mycoplasma fermentans from urine of human immunodeficiency vims type-1 infected patients. Arch Pathol Lab Med 1993; 117:511–514
    [Google Scholar]
  4. Lo S.-C., Hayes M. M., Wang R. Y-H., Pierce P. F., Kotani H., Shih J. W-K. Newly discovered mycoplasma isolated from patients infected with HIV. Lancet 1991; 338:1415–1418
    [Google Scholar]
  5. Grau O., Kovacic R., Griffais R., Montagnier L. Development of a selective and sensitive polymerase chain reaction assay for the detection of Mycoplasma pirum. FEMS Microbiol Lett 1993; 106:327–334
    [Google Scholar]
  6. De Barbeyrac B., Dupon M., Grau O. Mycoplasmas in patients infected with HIV-1. IOM Letters vol 4 11th International Congress of the International Organisation of Myco-plasmology (IOM); Orlando, FL, USA: July 14-19 199669
    [Google Scholar]
  7. Baseman J. B., Dallo S. F., Tully J. G., Rose D. L. Isolation and characterization of Mycoplasma genitalium strains from the human respiratory tract. J Clin Microbiol 1988; 26:2266–2269
    [Google Scholar]
  8. Renaudin H., Tully J. G., Bébéar C. In vitro susceptibilities of Mycoplasma genitalium to antibiotics. Antimicrob Agents Chemother 1992; 36:870–872
    [Google Scholar]
  9. Lind K., Lindhardt B. Ø., Schütten H. J., Blom J., Christiansen C. Serological cross-reactions between Mycoplasma genitalium and Mycoplasma pneumoniae. J Clin Microbiol 1984; 20:1036–1043
    [Google Scholar]
  10. Hayes M. M., Foo H.-H., Kotani H., Wear D. J., Lo S.-C. In vitro antibiotic susceptibility testing of different strains of Mycoplasma fermentans isolated from a variety of sources. Antimicrob Agents Chemother 1993; 37:2500–2503
    [Google Scholar]
  11. Hannan P. C. T. Antibiotic susceptibility of Mycoplasma fermentans strains from various sources and the development of resistance to aminoglycosides in vitro. J Med Microbiol 1995; 42:421–428
    [Google Scholar]
  12. Hayes M. M., Foo H.-H., Timenetsky J., Lo S.-C. In vitro antibiotic sensitivity testing of clinical isolates of Mycoplasma penetrans from patients with AIDS. Antimicrob Agents Chemother 1995; 39:1386–1387
    [Google Scholar]
  13. Jao R. L., Finland M. Susceptibility of Mycoplasma pneumoniae to 21 antibiotics in vitro. Am J Med Sci 1967; 253:639–650
    [Google Scholar]
  14. Stewart S. M., Burnet M. E., Young J. E. In-vitro sensitivity of strains of Mycoplasmas from human sources to antibiotics and to sodium aurothiomalate and tylosin tartrate. J Med Microbiol 1969; 2:287–292
    [Google Scholar]
  15. Braun P., Klein J. O., Kass E. H. Susceptibility of genital mycoplasmas to antimicrobial agents. Appl Microbiol 1970; 19:62–70
    [Google Scholar]
  16. Quentin C., Cantet P., Renaudin H., Bebear C. [Antibiotic sensitivity of mycoplasmas pathogenic for man.] Sensibilité aux antibiotiques des mycoplasmes pathogenes pour l’homme. Pathol Biol 1985; 33:205–212
    [Google Scholar]
  17. Waites K. B., Cassell G. H., Canupp K. C., Fernandes P. B. In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones. Antimicrob Agents Chemother 1988; 32:1500–1502
    [Google Scholar]
  18. Kenny G. E., Hooton T. M., Roberts M. C., Cartwright F. D., Hoyt J. Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method. Antimicrob Agents Chemother 1989; 33:103–107
    [Google Scholar]
  19. Kenny G. E., Cartwright F. D. Susceptibilities of Mycoplasma hominis and Ureaplasma urealyticum to two new quinolines, Sparfloxacin and WIN 57273. Antimicrob Agents Chemother 1991; 35:1515–1516
    [Google Scholar]
  20. Kenny G. E., Cartwright F. D. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycyclines in comparison with those to older tetracyclines. Antimicrob Agents Chemother 1994; 38:2628–2632
    [Google Scholar]
  21. Kenny G. E., Cartwright F. D. Susceptibility of Mycoplasma pneumoniae to several new quinolones, tetracycline, and erythromycin. Antimicrob Agents Chemother 1991; 35:587–589
    [Google Scholar]
  22. Waites K. B., Duffy L. B., Schmid T., Crabb D., Pate M. S., Cassell G. H. In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to Spar-floxacin and PD 127391. Antimicrob Agents Chemother 1991; 35:1181–1185
    [Google Scholar]
  23. Poulin S. A., Perkins R. E., Kundsin R. B. Antibiotic susceptibilites of AIDS-associated Mycoplasmas. J Clin Microbiol 1994; 32:1101–1103
    [Google Scholar]
  24. Furneri P. M., Bisignano G., Cerniglia G., Nicoletti G., Cesana M., Tempera G. In vitro antimycoplasmal activities of Rufloxacin and its metabolite MF 922. Antimicrob Agents Chemother 1994; 38:2651–2654
    [Google Scholar]
  25. Bébéar C. M., Renaudin H., Aydin M. D., Chantot J. F., Bébéar C. In-vitro activity of ketolides against mycoplasmas. J Antimicrob Chemother 1997; 39:669–670
    [Google Scholar]
  26. Del Guidice R. A., Tully J. G., Rose D. L., Cole R. M. Mycoplasma pirum sp. nov., a terminal structure mollcute from cell cultures. Int J Syst Bacteriol 1985; 35:285–291
    [Google Scholar]
  27. Tully J. G., Rose D. L., Baseman J. B., Dallo S. F., Lazzell A. L., Davis C. P. Mycoplasma pneumoniae and Mycoplasma genitalium mixture in synovial fluid isolate. J Clin Microbiol 1995; 33:1851–1855
    [Google Scholar]
  28. Jensen J. S., Hansen H. T., Lind K. Isolation of Mycoplasma genitalium from the male urethra. J Clin Microbiol 1996; 34:286–291
    [Google Scholar]
  29. Clyde W. A. Mycoplasma species identification based upon growth inhibition by specific antisera. J Immunol 1964; 92:958–965
    [Google Scholar]
  30. Tanner A. C., Wu C. C. Adaptation of the Sensititre broth microdilution technique to antimicrobial susceptibility testing of Mycoplasma gallisepticum. Avian Dis 1992; 36:714–717
    [Google Scholar]
  31. Hannan P. C. T., O’Hanlon P. J., Rogers N. H. In vitro evaluation of various quinolone antibacterial agents against veterinary mycoplasmas and porcine respiratory bacterial pathogens. Res Vet Sci 1989; 46:202–211
    [Google Scholar]
  32. Schmitt K., Dӓubener W., Bitter-Suermann D., Hadding U. A safe and efficient method for elimination of cell culture mycoplasmas using ciprofloxacin. J Immunol Methods 1988; 109:17–25
    [Google Scholar]
  33. Eaton M. D., Meicklejohn G., van Herick W. Studies on the etiology of primary atypical pneumonia. A filterable agent transmissable to cotton rats, hamsters, and chick embryos. J Exp Med 1944; 79:649–668
    [Google Scholar]
  34. Eaton M. D., Liu C. Studies on sensitivity to streptomycin of the atypical pneumonia agent. J Bacteriol 1957; 74:784–787
    [Google Scholar]
  35. Kubota H. Development of resistance to and dependence on streptomycin in Mycoplasma pneumoniae in vitro. Jpn J Microbiol 1974; 18:157–163
    [Google Scholar]
  36. Niitu Y., Kubota H., Hasegawa S., Komatsu S., Horikawa M., Suetake T. Susceptibility of Mycoplasma pneumoniae to antibiotics in vitro. Jpn J Microbiol 1974; 18:149–155
    [Google Scholar]
  37. Philips I., Shannon K. Aminoglycoside resistance. Br Med Bull 1984; 40:28–35
    [Google Scholar]
  38. Hannan P. C. T. Observations on the possible origin of Mycoplasma fermentans incognitus strain based on antibiotic sensitivity tests. J Antimicrob Chemother 1997; 39:25–30
    [Google Scholar]
  39. Hannan P. C. T., Kearns A. M., Sisson P. R., Freeman R. Differentiation of strains of M. fermentans from various sources by pyrolysis mass spectrometry. J Med Microbiol 1997; 46:348–353
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-47-12-1115
Loading
/content/journal/jmm/10.1099/00222615-47-12-1115
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error